Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Romas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Internal Medicine Journal|April 10, 2009
Clinical applications of RANK-ligand inhibitionE Romas
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Cytokines in the pathogenesis of osteoporosisE Romas, T J Martin
British Journal of Rheumatology|February 1, 1996
Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositisC Hill, E Romas, B Kirkham
Arthritis and Rheumatism|January 1, 1997
The arthropathy of fibroblastic rheumatismE Romas, M Finlay, T Woodruff
Internal Medicine Journal|August 25, 2016
Rheumatoid arthritis heralded by the hypereosinophilic syndromeJ Moxey, K Morrisroe, E Romas
Pathology|July 1, 1992
Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG kappa paraproteinemiaE Romas, E Storey, M Ayers, et al.
Critical Reviews in Eukaryotic Gene Expression|August 26, 1998
Interleukins in the control of osteoclast differentiationT J Martin, E Romas, M T Gillespie
The Journal of Rheumatology|April 1, 1995
Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhageE Romas, D R Henderson, B W Kirkham
Bone|February 22, 2002
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritisE Romas, M T Gillespie, T J Martin
Internal Medicine Journal|January 24, 2014
Whose responsibility is it to assess cardiovascular risk in patients with rheumatoid arthritis?A Quinlivan, O A Moore, E Romas, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Internal Medicine Journal|April 10, 2009
Clinical applications of RANK-ligand inhibitionE Romas
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Cytokines in the pathogenesis of osteoporosisE Romas, T J Martin
British Journal of Rheumatology|February 1, 1996
Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositisC Hill, E Romas, B Kirkham
Arthritis and Rheumatism|January 1, 1997
The arthropathy of fibroblastic rheumatismE Romas, M Finlay, T Woodruff
Internal Medicine Journal|August 25, 2016
Rheumatoid arthritis heralded by the hypereosinophilic syndromeJ Moxey, K Morrisroe, E Romas
Pathology|July 1, 1992
Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG kappa paraproteinemiaE Romas, E Storey, M Ayers, et al.
Critical Reviews in Eukaryotic Gene Expression|August 26, 1998
Interleukins in the control of osteoclast differentiationT J Martin, E Romas, M T Gillespie
The Journal of Rheumatology|April 1, 1995
Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhageE Romas, D R Henderson, B W Kirkham
Bone|February 22, 2002
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritisE Romas, M T Gillespie, T J Martin
Internal Medicine Journal|January 24, 2014
Whose responsibility is it to assess cardiovascular risk in patients with rheumatoid arthritis?A Quinlivan, O A Moore, E Romas, et al.
Pageof 3